Christopher Viehbacher
Director at Braveheart Bio; President and CEO at Biogen. Based in San Francisco, California.
- Rank
- 4810th of 14,452
- Companies held
- 2
- Largest holding
- BRVE, 66.4% of total
- Latest SEC filing
- Aug 7, 2026
What the $22.0M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Braveheart Bio BRVE Common Stock | Directly | 609,519 | $19.27 | $11.7M | 53.3% | Form 4, Aug 7, 2026 |
| Biogen BIIB Common Stock | Directly | 29,924 | $247.13 | $7.4M | 33.6% | Form 4, Feb 6, 2026 |
| Braveheart Bio BRVE Common Stock | Through CAV FAMILY LLC | 150,338 | $19.27 | $2.9M | 13.1% | Form 4, Aug 5, 2026 |
Share counts are the amounts Christopher Viehbacher reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 4807 | Richard J. Daly Executive Chairman, Broadridge Financial Solutions. Lake Success, NY | $22.0M |
| 4808 | William Meury Chief Executive Officer, Incyte. Wilmington, DE | $22.0M |
| 4809 | John O. Larsen Director, Alliant Energy. Oakland, CA | $22.0M |
| 4810 | Christopher Viehbacher Director, Braveheart Bio. San Francisco, CA | $22.0M |
| 4811 | Nathaniel Ru Director, Sweetgreen. Los Angeles, CA | $22.0M |
| 4812 | Amie Thuener O'Toole Chief Financial Officer, Broadcom. Palo Alto, CA | $22.0M |
| 4813 | Manuel Bronstein Chief Product Officer, Roblox. New York, NY | $22.0M |
Other Braveheart Bio insiders
All BRVE insiders- Travis Murdoch$141MCEO and President. #1160 overall
- David I. Malek$14.9MDirector. #6476 overall
- James Paul Rickey$11.8MChief Financial Officer. #7757 overall
- Michele A. Anderson$6.4MChief Development Officer. #12189 overall
- Jason Coloma V.$1.8MDirector. #5362 overall
Questions
How much stock does Christopher Viehbacher own?
Christopher Viehbacher holds $22,037,563 in listed stock based on SEC filings and current prices, mostly Braveheart Bio (BRVE). That ranks 4810th on the Stock Rich List.
Is this Christopher Viehbacher's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Christopher Viehbacher last buy or sell stock?
The most recent open-market trade on file is a purchase of 83,333 BRVE shares on Aug 7, 2026 at $18.00.